María Florencia Pavan

María Florencia Pavan

Auto-generated profile, based on publicly available information

María Florencia Pavan

Instituto de Química Física de los Materiales, Medio Ambiente y Energía (INQUIMAE), CONICET, FCEN, UBA, Ciudad Universitaria, Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2025 in Research Square
Verified
Preprint
Open access
PDF file
MPMaría Pignataro
María Pignataro
NFNatalia Fernández
Natalia Fernández
AGAlba Garay-Alvarez
Alba Garay-Alvarez
MPMaría Pavan
María Pavan
RMRafael Molina
Rafael Molina
Javier SantosJavier Santos
Javier Santos
Iron-sulfur clusters are essential cofactors for hundreds of proteins. In eukaryotic cells, the biogenesis of most iron-sulfur clusters occurs in the mitochondria and involves the Cys desulfurase supercomplex, which is activated by frataxin (FXN). The decrease of FXN expression, stability, and/or function results in Friedreich's ataxia (FA), a rare disease affecting 1 in 50,000 people. In this work, we propose modulating the conformational stability of FXN through nanobody interactions as a viable strategy to maintain FXN function. Several nanobodies specific to human FXN were selected via phage display, demonstrating a wide range of effects on Cys desulfurase activity. We focused on four nanobodies that exhibited strong interactions with FXN ( K D = 1–30 nM) and stabilized the pathogenic FXN variant G130V by increasing its Tm by 15°C. The interaction between nanobodies and FXN was characterized using various biophysical tools, including NMR, SAXS, and X-ray diffraction. Three of the nanobodies bind to a similar region, and the structures of the corresponding nanobody-FXN complexes were solved by X-ray diffraction, showing a similar binding mode. In contrast, the fourth nanobody binds to alpha-helix 1, as determined by NMR and SAXS. The biological effects of nanobody expression were studied in human cells. The subcellular localization, effect on cell viability, Fe-S-dependent enzymatic activities, and oxygen consumption rates were analyzed. The expression of nanobodies sharing the same binding mode did not alter these key metabolic variables, suggesting that the interaction with FXN did not disrupt the pathway. Overall, these results suggest that nanobodies can be employed as tutor mitochondrial proteins to investigate the function modulation of unstable pathogenic FXN variants in FA models.

3 January 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
MPMaría Florencia Pignataro
María Florencia Pignataro
NFNatalia Brenda Fernández
Natalia Brenda Fernández
AGAlba Garay-Alvarez
Alba Garay-Alvarez
MPMaría Florencia Pavan
María Florencia Pavan
RMRafael Molina Monterrubio
Rafael Molina Monterrubio
Javier SantosJavier Santos
Javier Santos
Iron-sulfur clusters are essential cofactors for the accurate cellular function of many proteins. In eukaryotic cells, the biogenesis of most iron-sulfur clusters occurs in the mitochondria and involves the action of the Cys desulfurase supercomplex, which is activated by the protein frataxin (FXN). The decrease of FXN expression and/or function results in Friedreich’s ataxia (FRDA). In this work, several nanobodies specific to human FXN were selected via phage display, demonstrating a wide range of effects on Cys desulfurase activity and a strong interaction with FXN. Nanobody interaction stabilized wild-type and FRDA-related FXN variants in vitro. FXN-nanobody complexes were characterized by NMR, SAXS, and X-ray crystallography. Additionally, Nanobody expression was studied in human cells. The subcellular localization, direct interaction with FXN by in situ proximity ligation assay, effect on cell viability, Fe-S-dependent enzymatic activities, and oxygen consumption rates were analyzed. Significantly, nanobody expression did not alter these key metabolic variables, suggesting that the interaction with FXN did not disrupt the pathway. As a whole, our results suggest that nanobodies can serve as binding partners for mitochondrial FXN. However, the specific effect of the nanobodies on the conformational stability of FRDA-related FXN variants in cells should be investigated.

9 December 2025 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
ELEduardo L. López
Eduardo L. López
MTMaría S. Tineo
María S. Tineo
FGFederico Di Gregorio
Federico Di Gregorio
MPMaría F. Pavan
María F. Pavan
Florencia BonninFlorencia Bonnin
Florencia Bonnin
Laura B. TalaricoLaura B. Talarico
Laura B. Talarico